Cargando…

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0

PURPOSE: We constructed Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 to expand studies in BladderBaSe on incidence, treatment outcomes, side effects, survival and health economic aspects of men and women with cancer in the urinary bladder, upper tract urothelial carcinoma (UTUC) (renal pelvis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Häggström, Christel, Hagberg, Oskar, Gårdmark, Truls, Aljabery, Firas, Ströck, Viveka, Hosseini, Abolfazl, Sherif, Amir, Malmstrom, Per-Uno, Söderkvist, Karin, Ullén, Anders, Jerlström, Tomas, Jahnson, Staffan, Liedberg, Fredrik, Holmberg, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772662/
https://www.ncbi.nlm.nih.gov/pubmed/36600418
http://dx.doi.org/10.1136/bmjopen-2022-064898
_version_ 1784855029166899200
author Häggström, Christel
Hagberg, Oskar
Gårdmark, Truls
Aljabery, Firas
Ströck, Viveka
Hosseini, Abolfazl
Sherif, Amir
Malmstrom, Per-Uno
Söderkvist, Karin
Ullén, Anders
Jerlström, Tomas
Jahnson, Staffan
Liedberg, Fredrik
Holmberg, Lars
author_facet Häggström, Christel
Hagberg, Oskar
Gårdmark, Truls
Aljabery, Firas
Ströck, Viveka
Hosseini, Abolfazl
Sherif, Amir
Malmstrom, Per-Uno
Söderkvist, Karin
Ullén, Anders
Jerlström, Tomas
Jahnson, Staffan
Liedberg, Fredrik
Holmberg, Lars
author_sort Häggström, Christel
collection PubMed
description PURPOSE: We constructed Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 to expand studies in BladderBaSe on incidence, treatment outcomes, side effects, survival and health economic aspects of men and women with cancer in the urinary bladder, upper tract urothelial carcinoma (UTUC) (renal pelvis and ureter) and urethral carcinoma. PARTICIPANTS: BladderBaSe 2.0 includes 53 298 patients with cancer in the urinary bladder, diagnosed from 1 January 1997 to 31 December 2019, and 961 patients with UTUC in the renal pelvis and 792 in the ureter, and 146 patients with urethral urothelial carcinoma, diagnosed from 1 January 2015 to 31 December 2019, and in total 275 816 participants in reference groups, free of cancer in the urinary tract, matched 1:5 on sex, age and county. FINDINGS TO DATE: To date, 18 published studies based on data from the BladderBaSe have investigated calendar time trends in survival; impact of gender, socioeconomic factors, tumour aggressiveness and hospital volume for radical cystectomy on prognosis; survival after radical cystectomy compared with radical radiotherapy; risk factors for complications and side effects after radical cystectomy such as thromboembolism, strictures of ureteroenterostomies and incisional hernia. FUTURE PLANS: The BladderBaSe initiators are currently investigating gender-dependent detection delays due to urinary tract infections; survival after non-muscle invasive bladder cancer with respect to the number of transurethral resections; short-term outcomes comparing open and robot-assisted radical cystectomy; studies on risk for intravesical recurrence after different diagnostic measures in UTUC, and suicide risk after bladder cancer diagnosis. The BladderBaSe project group is open for collaborations with national and international colleagues.
format Online
Article
Text
id pubmed-9772662
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-97726622022-12-23 Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 Häggström, Christel Hagberg, Oskar Gårdmark, Truls Aljabery, Firas Ströck, Viveka Hosseini, Abolfazl Sherif, Amir Malmstrom, Per-Uno Söderkvist, Karin Ullén, Anders Jerlström, Tomas Jahnson, Staffan Liedberg, Fredrik Holmberg, Lars BMJ Open Urology PURPOSE: We constructed Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 to expand studies in BladderBaSe on incidence, treatment outcomes, side effects, survival and health economic aspects of men and women with cancer in the urinary bladder, upper tract urothelial carcinoma (UTUC) (renal pelvis and ureter) and urethral carcinoma. PARTICIPANTS: BladderBaSe 2.0 includes 53 298 patients with cancer in the urinary bladder, diagnosed from 1 January 1997 to 31 December 2019, and 961 patients with UTUC in the renal pelvis and 792 in the ureter, and 146 patients with urethral urothelial carcinoma, diagnosed from 1 January 2015 to 31 December 2019, and in total 275 816 participants in reference groups, free of cancer in the urinary tract, matched 1:5 on sex, age and county. FINDINGS TO DATE: To date, 18 published studies based on data from the BladderBaSe have investigated calendar time trends in survival; impact of gender, socioeconomic factors, tumour aggressiveness and hospital volume for radical cystectomy on prognosis; survival after radical cystectomy compared with radical radiotherapy; risk factors for complications and side effects after radical cystectomy such as thromboembolism, strictures of ureteroenterostomies and incisional hernia. FUTURE PLANS: The BladderBaSe initiators are currently investigating gender-dependent detection delays due to urinary tract infections; survival after non-muscle invasive bladder cancer with respect to the number of transurethral resections; short-term outcomes comparing open and robot-assisted radical cystectomy; studies on risk for intravesical recurrence after different diagnostic measures in UTUC, and suicide risk after bladder cancer diagnosis. The BladderBaSe project group is open for collaborations with national and international colleagues. BMJ Publishing Group 2022-12-20 /pmc/articles/PMC9772662/ /pubmed/36600418 http://dx.doi.org/10.1136/bmjopen-2022-064898 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Urology
Häggström, Christel
Hagberg, Oskar
Gårdmark, Truls
Aljabery, Firas
Ströck, Viveka
Hosseini, Abolfazl
Sherif, Amir
Malmstrom, Per-Uno
Söderkvist, Karin
Ullén, Anders
Jerlström, Tomas
Jahnson, Staffan
Liedberg, Fredrik
Holmberg, Lars
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title_full Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title_fullStr Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title_full_unstemmed Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title_short Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
title_sort cohort profile: bladder cancer data base sweden (bladderbase) 2.0
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772662/
https://www.ncbi.nlm.nih.gov/pubmed/36600418
http://dx.doi.org/10.1136/bmjopen-2022-064898
work_keys_str_mv AT haggstromchristel cohortprofilebladdercancerdatabaseswedenbladderbase20
AT hagbergoskar cohortprofilebladdercancerdatabaseswedenbladderbase20
AT gardmarktruls cohortprofilebladdercancerdatabaseswedenbladderbase20
AT aljaberyfiras cohortprofilebladdercancerdatabaseswedenbladderbase20
AT strockviveka cohortprofilebladdercancerdatabaseswedenbladderbase20
AT hosseiniabolfazl cohortprofilebladdercancerdatabaseswedenbladderbase20
AT sherifamir cohortprofilebladdercancerdatabaseswedenbladderbase20
AT malmstromperuno cohortprofilebladdercancerdatabaseswedenbladderbase20
AT soderkvistkarin cohortprofilebladdercancerdatabaseswedenbladderbase20
AT ullenanders cohortprofilebladdercancerdatabaseswedenbladderbase20
AT jerlstromtomas cohortprofilebladdercancerdatabaseswedenbladderbase20
AT jahnsonstaffan cohortprofilebladdercancerdatabaseswedenbladderbase20
AT liedbergfredrik cohortprofilebladdercancerdatabaseswedenbladderbase20
AT holmberglars cohortprofilebladdercancerdatabaseswedenbladderbase20